B. Metzler seel. Sohn & Co. Holding AG Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 12,509 shares of the company’s stock, valued at approximately $5,084,000.

Several other large investors also recently made changes to their positions in the stock. Capital World Investors grew its position in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares during the period. Lee Danner & Bass Inc. acquired a new position in HCA Healthcare during the second quarter worth approximately $131,527,000. Darsana Capital Partners LP lifted its position in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the last quarter. Swedbank AB bought a new stake in HCA Healthcare in the 1st quarter valued at $95,882,000. Finally, Argent Capital Management LLC boosted its position in HCA Healthcare by 1,215.6% during the second quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock worth $51,493,000 after purchasing an additional 148,092 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock worth $5,608,990. 1.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on HCA shares. Leerink Partners raised their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. TD Cowen decreased their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. KeyCorp reduced their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Trading Down 0.2 %

Shares of HCA stock opened at $335.11 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market capitalization of $84.88 billion, a P/E ratio of 15.05, a P/E/G ratio of 1.32 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $245.03 and a twelve month high of $417.14. The stock’s fifty day simple moving average is $383.10 and its 200 day simple moving average is $358.30.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.79%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.